Home / Drug shortages / Lisdexamfetamine Dimesylate Capsule

Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 07/14/2023.

Shortage Details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0480-3569-01
Dosage Form
Capsule
Presentation
Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01)
Initial Posting
07/14/2023
Revised Date

FDA data resources